6533b861fe1ef96bd12c4f20
RESEARCH PRODUCT
Rationale and evidence on the use of tocilizumab in COVID-19: A systematic review. Authors’ reply
Mariachiara IppolitoAndrea CortegianiSharon Einavsubject
lcsh:RC705-779Pulmonary and Respiratory Medicine2019-20 coronavirus outbreakmedicine.medical_specialtyCoronavirus disease 2019 (COVID-19)SARS-CoV-2business.industrySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)MEDLINECOVID-19lcsh:Diseases of the respiratory systemAntibodies Monoclonal HumanizedSeverity of Illness Indexchemistry.chemical_compoundTocilizumabchemistrySeverity of illnessHumansMedicinebusinessIntensive care medicineLetter to the Editor| year | journal | country | edition | language |
|---|---|---|---|---|
| 2021-01-01 |